The Clone Reimagined

only 31 of every 100 human conceptions complete the journey.

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Getty Images

Normal development is an inefficient process – only 31 of every 100 human conceptions complete the journey. Development via somatic cell nuclear transfer (SCNT), under the direction of adult DNA from a specialized cell is even less efficient, with success rates of about one in 300 or worse. Although nearly as many questions remain as when SCNT was first attempted half a century ago, researchers are closing in on why it is so difficult to emulate normal development starting with this most unusual genetic headquarters.

The major distinction between development via sperm and egg versus SCNT is a profound perturbation of gene expression. The deviations arise from various sources, including influences of the culture medium and factors in the nucleoplasm and cytoplasm. When all goes well, morphogens interact to effectively reprogram the new nucleus, which is vital to resetting the developmental program. But even the most prominent researchers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ricki Lewis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours